Biogen Announces Webcast of Investor R&D Day

Category:

Monday, October 5, 2015 4:01 pm EDT

Dateline:

CAMBRIDGE, Mass.

Public Company Information:

NASDAQ:
BIIB
US09062X1037

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ:BIIB) today announced that it will hold an Investor R&D Day with live webcast on Tuesday, November 3, 2015 at 10:00 a.m. ET. To access the live webcast, please go to the investor relations section of Biogen’s website at www.biogen.com. Following the live webcast, an archived version of the webcast will be available at the same URL, for one month.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.

Contact:

Biogen
Karen Jewell, 781-464-2442
Investor Relations